News

MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...
Roger Cook has given a blunt message to Western Australian’s who are suffering flu symptoms as cases of the virus soar in the ...
The approval was based on data from the pivotal Phase IIb/III CLEVER trial which assessed a single dose of the antibody.
The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...
MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.
Approval of Enflonsia was based on data from the Phase IIb/III CLEVER trial, which showed a 60.5% reduction in medically ...
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
Integrated DNA Technologies (IDT), a global genomics provider headquartered in Coralville, is expanding its infectious ...
A case of bird flu has been found in poultry in County Durham, Defra has confirmed. The news comes weeks after the government lifted the national mandatory housing order for kept birds. Defra said ...
For the first time since the start of the COVID-19 pandemic, the number of Nova Scotians dying from influenza exceeds that of ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...